Conference Call with Galaxy Surfactants Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Galaxy Surfactants announced Q3FY26 results Total Income: Rs 1,334.3 crore against Rs 1,045.7 crore during Q3FY25, change 28%. EBITDA: Rs 124.2 crore against Rs 109.6 crore during Q3FY25, change 13%. EBITDA Margin: 9.3% for Q3FY26. PBT: Rs 84.9 crore against Rs 76.9 crore during Q3FY25, change 10%. PAT: Rs 59 crore against Rs 64.6 crore during Q3FY25, change -9%. PAT Margin: 4.4% for Q3FY26. EPS: Rs 16.63 for Q3FY26. K. Natarajan, Managing Director, Galaxy Surfactants, said: “The quarter gone by reflects a resilient performance in Q3FY26 despite multiple market headwinds. Consolidated volumes remained flat on YoY, with high single-digit growth in Specialty Care Products offsetting softness in the Performance Surfactants segment. EBITDA increased by 13% on YoY to Rs 124 crore, supported by stronger contributions from the Specialty segment in India and ROW region. Consequently, EBITDA/MT improved to Rs 20,156/MT reflecting a favorable product mix and disciplined cost management. In India, domestic volumes grew in the mid-single digit YoY, driven by strong traction from Non-Tier-1and D2C customers. While the Performance segment declined due to ongoing reformulation at a key Tier-1 account and temporary demand disruption following GST-related inventory adjustments in October month, the Specialty segment delivered a robust 35% YoY volume growth, cushioning Tier-1 softness and reinstating momentum across Tier-2 and Tier-3 accounts. In the AMET region volumes declined in the high teens YoY, primarily due to heightened competitive intensity. Meanwhile ROW region continued to support portfolio resilience, delivering mid-single digit YoY volume growth, led by healthy demand across Latin America and Europe in both Performance and Specialty segments. Prestige Specialty products from the Company’s Tri-K subsidiary continued to demonstrate strong momentum, enhancing the premium mix contribution. Although U.S. reciprocal tariffs weighed on India-origin Specialty exports during the quarter the recent tariff rate reduction is expected to mitigate this impact going forward. With India’s improving growth environment following GST reforms of AMET volumes in coming quarters, incremental benefits from the U.S.–India tariff revision, and continued premiumization of the Specialty portfolio, the Company remains confident of regaining growth momentum in the coming quarters.” Result PDF